{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:18:51Z","timestamp":1793755131878,"version":"4.6.1"},"reference-count":129,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/xzri9189","type":"journal-article","created":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T22:25:33Z","timestamp":1722205533000},"page":"3259-3279","source":"Crossref","is-referenced-by-count":21,"title":["Cancer-associated adipocytes in the ovarian cancer microenvironment"],"prefix":"10.62347","volume":"14","author":[{"given":"Qiuling","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","unstructured":"Webb PM and Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2017; 41: 3-14.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA and Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer 2023; 4: 1239-1257.","journal-title":"Nat Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard I","year":"2019","unstructured":"Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E and Harter P; PAOLA-1 Investigators. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N Engl J Med 2019; 381: 2416-2428.","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00429-004-0446-6","article-title":"A comparative study of the structure of human and murine greater omentum","volume":"209","author":"Wilkosz","year":"2005","unstructured":"Wilkosz S, Ireland G, Khwaja N, Walker M, Butt R, de Giorgio-Miller A and Herrick SE. A comparative study of the structure of human and murine greater omentum. Anat Embryol (Berl) 2005; 209: 251-261.","journal-title":"Anat Embryol (Berl)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/obr.12450","article-title":"Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression","volume":"17","author":"Chkourko Gusky","year":"2016","unstructured":"Chkourko Gusky H, Diedrich J, MacDougald OA and Podgorski I. Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression. Obes Rev 2016; 17: 1015-1029.","journal-title":"Obes Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12935-023-02854-5","article-title":"Tumor microenvironment in ovarian cancer peritoneal metastasis","volume":"23","author":"Mei","year":"2023","unstructured":"Mei S, Chen X, Wang K and Chen Y. Tumor microenvironment in ovarian cancer peritoneal metastasis. Cancer Cell Int 2023; 23: 11.","journal-title":"Cancer Cell Int"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Zhang Y, Nowicka A, Solley TN, Wei C, Parikh A, Court L, Burks JK, Andreeff M, Woodward WA, Dadbin A, Kolonin MG, Lu KH and Klopp AH. Stromal cells derived from visceral and obese adipose tissue promote growth of ovarian cancers. PLoS One 2015; 10: e0136361.","DOI":"10.1371\/journal.pone.0136361"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.10.017","article-title":"Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment","volume":"525","author":"Essa","year":"2022","unstructured":"Essa N, O’Connell F, Prina-Mello A, O’Sullivan J and Marcone S. Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment. Cancer Lett 2022; 525: 1-8.","journal-title":"Cancer Lett"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/0008-5472.CAN-23-0505","article-title":"Fueling the tumor microenvironment with cancer-associated adipocytes","volume":"83","author":"Bouche","year":"2023","unstructured":"Bouche C and Quail DF. Fueling the tumor microenvironment with cancer-associated adipocytes. Cancer Res 2023; 83: 1170-1172.","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.trecan.2018.03.004","article-title":"Cancer as a matter of fat: the crosstalk between adipose tissue and tumors","volume":"4","author":"Lengyel","year":"2018","unstructured":"Lengyel E, Makowski L, DiGiovanni J and Kolonin MG. Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends Cancer 2018; 4: 374-384.","journal-title":"Trends Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"111362","DOI":"10.1016\/j.celrep.2022.111362","article-title":"Adipocyte mesenchymal transition contributes to mammary tumor progression","volume":"40","author":"Zhu","year":"2022","unstructured":"Zhu Q, Zhu Y, Hepler C, Zhang Q, Park J, Gliniak C, Henry GH, Crewe C, Bu D, Zhang Z, Zhao S, Morley T, Li N, Kim DS, Strand D, Deng Y, Robino JJ, Varlamov O, Gordillo R, Kolonin MG, Kusminski CM, Gupta RK and Scherer PE. Adipocyte mesenchymal transition contributes to mammary tumor progression. Cell Rep 2022; 40: 111362.","journal-title":"Cell Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-052110-115718","article-title":"Adipogenesis: from stem cell to adipocyte","volume":"81","author":"Tang","year":"2012","unstructured":"Tang QQ and Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 2012; 81: 715-736.","journal-title":"Annu Rev Biochem"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.plipres.2017.11.002","article-title":"Adipocyte biology in breast cancer: from silent bystander to active facilitator","volume":"69","author":"Choi","year":"2018","unstructured":"Choi J, Cha YJ and Koo JS. Adipocyte biology in breast cancer: from silent bystander to active facilitator. Prog Lipid Res 2018; 69: 11-20.","journal-title":"Prog Lipid Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jemt.22972","article-title":"Morphometric study of adipocytes on breast cancer by means of photonic microscopy and image analysis","volume":"81","author":"Su&#xE1","year":"2018","unstructured":"Suárez-Nájera LE, Chanona-Pérez JJ, Valdivia-Flores A, Marrero-Rodríguez D, Salcedo-Vargas M, García-Ruiz DI and Castro-Reyes MA. Morphometric study of adipocytes on breast cancer by means of photonic microscopy and image analysis. Microsc Res Tech 2018; 81: 240-249.","journal-title":"Microsc Res Tech"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/ijms17010124","article-title":"Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules","volume":"17","author":"Moseti","year":"2016","unstructured":"Moseti D, Regassa A and Kim WK. Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. Int J Mol Sci 2016; 17: 124.","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","article-title":"Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion","volume":"71","author":"Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, Garrido I, Escourrou G, Valet P and Muller C. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011; 71: 2455-2465.","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/cancers15020502","article-title":"Emphasis on adipocyte transformation: anti-inflammatory agents to prevent the development of cancer-associated adipocytes","volume":"15","author":"Na","year":"2023","unstructured":"Na H, Song Y and Lee HW. Emphasis on adipocyte transformation: anti-inflammatory agents to prevent the development of cancer-associated adipocytes. Cancers (Basel) 2023; 15: 502.","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s11658-023-00476-3","article-title":"Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche","volume":"28","author":"Simiczyjew","year":"2023","unstructured":"Simiczyjew A, Wądzyńska J, Pietraszek-Gremplewicz K, Kot M, Ziętek M, Matkowski R and Nowak D. Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche. Cell Mol Biol Lett 2023; 28: 58.","journal-title":"Cell Mol Biol Lett"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"111498","DOI":"10.1016\/j.mce.2021.111498","article-title":"Editorial for special issue on “endocrinology of adipokines”","volume":"539","author":"Magnan","year":"2022","unstructured":"Magnan C and Valet P. Editorial for special issue on “endocrinology of adipokines”. Mol Cell Endocrinol 2022; 539: 111498.","journal-title":"Mol Cell Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","article-title":"Obesity, inflammation, and cancer","volume":"11","author":"Deng","year":"2016","unstructured":"Deng T, Lyon CJ, Bergin S, Caligiuri MA and Hsueh WA. Obesity, inflammation, and cancer. Annu Rev Pathol 2016; 11: 421-449.","journal-title":"Annu Rev Pathol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"622468","DOI":"10.3389\/fimmu.2020.622468","article-title":"The role of the adipokine leptin in immune cell function in health and disease","volume":"11","author":"Kiernan","year":"2021","unstructured":"Kiernan K and MacIver NJ. The role of the adipokine leptin in immune cell function in health and disease. Front Immunol 2021; 11: 622468.","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.3390\/cancers15174250","article-title":"Role of leptin and adiponectin in carcinogenesis","volume":"15","author":"Bocian-Jastrz&#x119","year":"2023","unstructured":"Bocian-Jastrzębska A, Malczewska-Herman A and Kos-Kudła B. Role of leptin and adiponectin in carcinogenesis. Cancers (Basel) 2023; 15: 4250.","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ding Y, Cao Y, Wang B, Wang L, Zhang Y, Zhang D, Chen X, Li M and Wang C. APPL1-mediating leptin signaling contributes to proliferation and migration of cancer cells. PLoS One 2016; 11: e0166172.","DOI":"10.1371\/journal.pone.0166172"},{"key":"ref24","unstructured":"Chen C, Chang YC, Lan MS and Breslin M. [Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK\/ERK1\/2 and PI3K\/Akt signaling pathways. Int J Oncol 2016; 49: 847."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1530\/REP-22-0443","article-title":"Visfatin increases the invasive potential of ovarian granulosa tumor spheroids by reprogramming glucose metabolism","volume":"165","author":"Gogola-Mruk","year":"2023","unstructured":"Gogola-Mruk J, Marynowicz W, Krawczyk K and Ptak A. Visfatin increases the invasive potential of ovarian granulosa tumor spheroids by reprogramming glucose metabolism. Reproduction 2023; 165: 521-531.","journal-title":"Reproduction"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"110686","DOI":"10.1016\/j.cellsig.2023.110686","article-title":"Visfatin-induced upregulation of lipogenesis via EGFR\/AKT\/GSK3β pathway promotes breast cancer cell growth","volume":"107","author":"Rajput","year":"2023","unstructured":"Rajput PK, Varghese JF, Srivastava AK, Kumar U and Yadav UCS. Visfatin-induced upregulation of lipogenesis via EGFR\/AKT\/GSK3β pathway promotes breast cancer cell growth. Cell Signal 2023; 107: 110686.","journal-title":"Cell Signal"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.1074\/jbc.M114.632141","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, leads to altered carbohydrate metabolism in cancer cells","volume":"290","author":"Tan","year":"2015","unstructured":"Tan B, Dong S, Shepard RL, Kays L, Roth KD, Geeganage S, Kuo MS and Zhao G. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, leads to altered carbohydrate metabolism in cancer cells. J Biol Chem 2015; 290: 15812-15824.","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/ijo.2022.5365","article-title":"Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5-FU by promoting the SDF-1\/CXCR4\/Akt axis","volume":"60","author":"Zhao","year":"2022","unstructured":"Zhao Q, Long Y, Cheng W, Huang Y, Li J, Li Y, Li X, Guo X, Li Y, Li G, Gong K and Zhang J. Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5-FU by promoting the SDF-1\/CXCR4\/Akt axis. Int J Oncol 2022; 60:75.","journal-title":"Int J Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1177\/15353702231191206","article-title":"Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes","volume":"248","author":"Liu","year":"2023","unstructured":"Liu CW, Peng HY, Siao AC, Tsuei YW, Lin YY, Shiah SG, Shih LJ, Yeh CC, Lee SW and Kao YH. Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes. Exp Biol Med (Maywood) 2023; 248: 1695-1707.","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1111\/cas.13704","article-title":"Resistin facilitates metastasis of lung adenocarcinoma through the TLR4\/Src\/EGFR\/PI3K\/NF-κB pathway","volume":"109","author":"Gong","year":"2018","unstructured":"Gong WJ, Liu JY, Yin JY, Cui JJ, Xiao D, Zhuo W, Luo C, Liu RJ, Li X, Zhang W, Zhou HH and Liu ZQ. Resistin facilitates metastasis of lung adenocarcinoma through the TLR4\/Src\/EGFR\/PI3K\/NF-κB pathway. Cancer Sci 2018; 109: 2391-2400.","journal-title":"Cancer Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3324\/haematol.2016.154062","article-title":"Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression","volume":"102","author":"Pang","year":"2017","unstructured":"Pang J, Shi Q, Liu Z, He J, Liu H, Lin P, Cui J and Yang J. Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression. Haematologica 2017; 102: 1273-1280.","journal-title":"Haematologica"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"12522","DOI":"10.1038\/s41598-018-30978-6","article-title":"Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition","volume":"8","author":"Qiu","year":"2018","unstructured":"Qiu L, Zhang GF, Yu L, Wang HY, Jia XJ and Wang TJ. Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition. Sci Rep 2018; 8: 12522.","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"215616","DOI":"10.1016\/j.canlet.2022.215616","article-title":"Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism","volume":"534","author":"Lyu","year":"2022","unstructured":"Lyu X, Zhang Q, Fares HM, Wang Y, Han Y and Sun L. Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism. Cancer Lett 2022; 534: 215616.","journal-title":"Cancer Lett"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Lehr S, Hartwig S, Lamers D, Famulla S, Müller S, Hanisch FG, Cuvelier C, Ruige J, Eckardt K, Ouwens DM, Sell H and Eckel J. Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 2012; 11: M111.010504.","DOI":"10.1074\/mcp.M111.010504"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.18632\/oncotarget.1963","article-title":"Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK\/Sirt1\/PGC-1α signaling","volume":"5","author":"Huang","year":"2014","unstructured":"Huang B, Cheng X, Wang D, Peng M, Xue Z, Da Y, Zhang N, Yao Z, Li M, Xu A and Zhang R. Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK\/Sirt1\/PGC-1α signaling. Oncotarget 2014; 5: 4732-4745.","journal-title":"Oncotarget"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/cphy.c180009","article-title":"Impact of estrogens on the regulation of white, beige, and brown adipose tissue depots","volume":"9","author":"Bernasochi","year":"2019","unstructured":"Bernasochi GB, Bell JR, Simpson ER, Delbridge LMD and Boon WC. Impact of estrogens on the regulation of white, beige, and brown adipose tissue depots. Compr Physiol 2019; 9: 457-475.","journal-title":"Compr Physiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.steroids.2014.12.013","article-title":"Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers","volume":"99","author":"Brown","year":"2015","unstructured":"Brown SB and Hankinson SE. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers. Steroids 2015; 99: 8-10.","journal-title":"Steroids"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00432-019-02872-9","article-title":"Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer","volume":"145","author":"Anestis","year":"2019","unstructured":"Anestis A, Sarantis P, Theocharis S, Zoi I, Tryfonopoulos D, Korogiannos A, Koumarianou A, Xingi E, Thomaidou D, Kontos M, Papavassiliou AG and Karamouzis MV. Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer. J Cancer Res Clin Oncol 2019; 145: 1221-1233.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/1878-0261.12362","article-title":"Feedback control of the CXCR7\/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer","volume":"12","author":"Benhadjeba","year":"2018","unstructured":"Benhadjeba S, Edjekouane L, Sauvé K, Carmona E and Tremblay A. Feedback control of the CXCR7\/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer. Mol Oncol 2018; 12: 1689-1705.","journal-title":"Mol Oncol"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Bossard C, Busson M, Vindrieux D, Gaudin F, Machelon V, Brigitte M, Jacquard C, Pillon A, Balaguer P, Balabanian K and Lazennec G. Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer. PLoS One 2012; 7: e44787.","DOI":"10.1371\/journal.pone.0044787"},{"key":"ref41","unstructured":"Pons DG, Sastre-Serra J, Nadal-Serrano M, Oliver A, García-Bonafé M, Bover I, Roca P and Oliver J. Initial activation status of the antioxidant response determines sensitivity to carboplatin\/paclitaxel treatment of ovarian cancer. Anticancer Res 2012; 32: 4723-4728."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/ijc.28565","article-title":"Unbalanced estrogen metabolism in ovarian cancer","volume":"134","author":"Zahid","year":"2014","unstructured":"Zahid M, Beseler CL, Hall JB, LeVan T, Cavalieri EL and Rogan EG. Unbalanced estrogen metabolism in ovarian cancer. Int J Cancer 2014; 134: 2414-2423.","journal-title":"Int J Cancer"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/biom11091355","article-title":"TNF-α increases IP-10 expression in MCF-7 breast cancer cells via activation of the JNK\/c-Jun pathways","volume":"11","author":"Kochumon","year":"2021","unstructured":"Kochumon S, Al-Sayyar A, Jacob T, Hasan A, Al-Mulla F, Sindhu S and Ahmad R. TNF-α increases IP-10 expression in MCF-7 breast cancer cells via activation of the JNK\/c-Jun pathways. Biomolecules 2021; 11: 1355.","journal-title":"Biomolecules"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"684505","DOI":"10.3389\/fcell.2021.684505","article-title":"Cancer-associated fibroblast-derived interleukin-8 promotes ovarian cancer cell stemness and malignancy through the Notch3-mediated signaling","volume":"9","author":"Ji","year":"2021","unstructured":"Ji Z, Tian W, Gao W, Zang R, Wang H and Yang G. Cancer-associated fibroblast-derived interleukin-8 promotes ovarian cancer cell stemness and malignancy through the Notch3-mediated signaling. Front Cell Dev Biol 2021; 9: 684505.","journal-title":"Front Cell Dev Biol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00262-019-02445-2","article-title":"IL-17A promotes fatty acid uptake through the IL-17A\/IL-17RA\/p-STAT3\/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment","volume":"69","author":"Yu","year":"2020","unstructured":"Yu C, Niu X, Du Y, Chen Y, Liu X, Xu L, Iwakura Y, Ma X, Li Y, Yao Z and Deng W. IL-17A promotes fatty acid uptake through the IL-17A\/IL-17RA\/p-STAT3\/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment. Cancer Immunol Immunother 2020; 69: 115-126.","journal-title":"Cancer Immunol Immunother"},{"key":"ref46","unstructured":"Furukawa S, Soeda S, Kiko Y, Suzuki O, Hashimoto Y, Watanabe T, Nishiyama H, Tasaki K, Hojo H, Abe M and Fujimori K. MCP-1 promotes invasion and adhesion of human ovarian cancer cells. Anticancer Res 2013; 33: 4785-4790."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41388-019-1090-1","article-title":"MCP-1\/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis","volume":"39","author":"Sun","year":"2020","unstructured":"Sun C, Li X, Guo E, Li N, Zhou B, Lu H, Huang J, Xia M, Shan W, Wang B, Li K, Weng D, Xu X, Gao Q, Wang S, Hu J, Lu Y, Mills GB and Chen G. MCP-1\/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. Oncogene 2020; 39: 1681-1695.","journal-title":"Oncogene"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X and Wang H. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 2017; 66: 157-167.","journal-title":"Gut"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/exd.14681","article-title":"Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas","volume":"32","author":"Ohuchi","year":"2023","unstructured":"Ohuchi K, Amagai R, Ikawa T, Muto Y, Roh Y, Endo J, Maekawa T, Kambayashi Y, Asano Y and Fujimura T. Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas. Exp Dermatol 2023; 32: 50-59.","journal-title":"Exp Dermatol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"166665","DOI":"10.1016\/j.bbadis.2023.166665","article-title":"FGFR2 upregulates PAI-1 via JAK2\/STAT3 signaling to induce M2 polarization of macrophages in colorectal cancer","volume":"1869","author":"Li","year":"2023","unstructured":"Li Y, Shi Y, Zhang X, Li P, Ma L, Hu P, Xu L, Dai Y, Xia S and Qiu H. FGFR2 upregulates PAI-1 via JAK2\/STAT3 signaling to induce M2 polarization of macrophages in colorectal cancer. Biochim Biophys Acta Mol Basis Dis 2023; 1869: 166665.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Tseng YJ, Lee CH, Chen WY, Yang JL and Tzeng HT. Inhibition of PAI-1 blocks PD-L1 endocytosis and improves the response of melanoma cells to immune checkpoint blockade. J Invest Dermatol 2021; 141: 2690-2698, e2696.","DOI":"10.1016\/j.jid.2021.03.030"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1038\/onc.2016.112","article-title":"TNF-α modulates genome-wide redistribution of ΔNp63α\/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer","volume":"35","author":"Si","year":"2016","unstructured":"Si H, Lu H, Yang X, Mattox A, Jang M, Bian Y, Sano E, Viadiu H, Yan B, Yau C, Ng S, Lee SK, Romano RA, Davis S, Walker RL, Xiao W, Sun H, Wei L, Sinha S, Benz CC, Stuart JM, Meltzer PS, Van Waes C and Chen Z. TNF-α modulates genome-wide redistribution of ΔNp63α\/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. Oncogene 2016; 35: 5781-5794.","journal-title":"Oncogene"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/cancers15030627","article-title":"Tumour necrosis factor-alpha (TNF-α)-induced metastatic phenotype in colorectal cancer epithelial cells: mechanistic support for the role of microRNA-21","volume":"15","author":"AG","year":"2023","unstructured":"Alotaibi AG, Li JV and Gooderham NJ. Tumour necrosis factor-alpha (TNF-α)-induced metastatic phenotype in colorectal cancer epithelial cells: mechanistic support for the role of microRNA-21. Cancers (Basel) 2023; 15: 627.","journal-title":"Cancers (Basel)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fimmu.2018.00444","article-title":"Tumor necrosis factor α and regulatory T cells in oncoimmunology","volume":"9","author":"Salomon","year":"2018","unstructured":"Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E and Cohen JL. Tumor necrosis factor α and regulatory T cells in oncoimmunology. Front Immunol 2018; 9: 444.","journal-title":"Front Immunol"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Beloribi-Djefaflia S, Vasseur S and Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 2016; 5: e189.","DOI":"10.1038\/oncsis.2015.49"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-016-0163-7","article-title":"Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration","volume":"5","author":"Balaban","year":"2017","unstructured":"Balaban S, Shearer RF, Lee LS, van Geldermalsen M, Schreuder M, Shtein HC, Cairns R, Thomas KC, Fazakerley DJ, Grewal T, Holst J, Saunders DN and Hoy AJ. Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration. Cancer Metab 2017; 5: 1.","journal-title":"Cancer Metab"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Cooke M and Kazanietz MG. Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity. Sci Signal 2022; 15: eabo0264.","DOI":"10.1126\/scisignal.abo0264"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/187152012800228661","article-title":"Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death","volume":"12","author":"Mullen","year":"2012","unstructured":"Mullen TD and Obeid LM. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med Chem 2012; 12: 340-363.","journal-title":"Anticancer Agents Med Chem"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","unstructured":"Petruzzelli M, Schweiger M, Schreiber R, Campos-Olivas R, Tsoli M, Allen J, Swarbrick M, Rose-John S, Rincon M, Robertson G, Zechner R and Wagner EF. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab 2014; 20: 433-447.","journal-title":"Cell Metab"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil&#xE9","year":"2014","unstructured":"Argilés JM, Busquets S, Stemmler B and López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014; 14: 754-762.","journal-title":"Nat Rev Cancer"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Schoettl T, Fischer IP and Ussar S. Heterogeneity of adipose tissue in development and metabolic function. J Exp Biol 2018; 221: jeb162958.","DOI":"10.1242\/jeb.162958"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1161\/CIRCRESAHA.120.316203","article-title":"Leukocyte heterogeneity in adipose tissue, including in obesity","volume":"126","author":"Weinstock","year":"2020","unstructured":"Weinstock A, Moura Silva H, Moore KJ, Schmidt AM and Fisher EA. Leukocyte heterogeneity in adipose tissue, including in obesity. Circ Res 2020; 126: 1590-1612.","journal-title":"Circ Res"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K and Lengyel E. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011; 17: 1498-1503.","journal-title":"Nat Med"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Wang F, Jin F, Peng S, Li C, Wang L and Wang S. Adipocyte-derived CCDC3 promotes tumorigenesis in epithelial ovarian cancer through the Wnt\/ß-catenin signalling pathway. Biochem Biophys Rep 2023; 35: 101507.","DOI":"10.1016\/j.bbrep.2023.101507"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1515\/med-2022-0422","article-title":"Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation","volume":"17","author":"Dai","year":"2022","unstructured":"Dai L, Wang C, Wang W, Song K, Ye T, Zhu J and Di W. Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation. Open Med (Wars) 2022; 17: 229-238.","journal-title":"Open Med (Wars)"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G and Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11-20.","journal-title":"Cell Metab"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/1878-0261.13208","article-title":"SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK","volume":"16","author":"Shi","year":"2022","unstructured":"Shi X, Yu X, Wang J, Bian S, Li Q, Fu F, Zou X, Zhang L, Bast RC Jr, Lu Z, Guo L, Chen Y and Zhou J. SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK. Mol Oncol 2022; 16: 2558-2574.","journal-title":"Mol Oncol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40164-022-00358-y","article-title":"Sphingosine kinase 1 contributes to the metastatic potential of epithelial ovarian cancer to the adipocyte-rich niche","volume":"11","author":"Wang","year":"2022","unstructured":"Wang C, Ye T, Wang W, Song K, Zhu J, Dai L and Di W. Sphingosine kinase 1 contributes to the metastatic potential of epithelial ovarian cancer to the adipocyte-rich niche. Exp Hematol Oncol 2022; 11: 102.","journal-title":"Exp Hematol Oncol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/ijc.33770","article-title":"Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer","volume":"149","author":"Iyoshi","year":"2021","unstructured":"Iyoshi S, Yoshihara M, Nakamura K, Sugiyama M, Koya Y, Kitami K, Uno K, Mogi K, Tano S, Tomita H, Kajiwara K, Taki M, Yamaguchi S, Nawa A and Kajiyama H. Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer. Int J Cancer 2021; 149: 1961-1972.","journal-title":"Int J Cancer"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12094-023-03240-3","article-title":"Delivery of SIRT1 by cancer-associated adipocyte-derived extracellular vesicles regulates immune response and tumorigenesis of ovarian cancer cells","volume":"26","author":"Zheng","year":"2024","unstructured":"Zheng Q, Du X, Zhang J, Liu Y, Dong W, Dai X and Gu D. Delivery of SIRT1 by cancer-associated adipocyte-derived extracellular vesicles regulates immune response and tumorigenesis of ovarian cancer cells. Clin Transl Oncol 2024; 26: 190-203.","journal-title":"Clin Transl Oncol"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Wu B, Sun X, Gupta HB, Yuan B, Li J, Ge F, Chiang HC, Zhang X, Zhang C, Zhang D, Yang J, Hu Y, Curiel TJ and Li R. Adipose PD-L1 modulates PD-1\/PD-L1 checkpoint blockade immunotherapy efficacy in breast cancer. Oncoimmunology 2018; 7: e1500107.","DOI":"10.1080\/2162402X.2018.1500107"},{"key":"ref72","unstructured":"Gálvez I, Hinchado MD, Martín-Cordero L, Morán-Plata FJ, Graham G, Francisco-Morcillo J and Ortega E. The anti-inflammatory and bioregulatory effects of habitual exercise in high-fat diet-induced obesity involve crown-like structures and MCP-1 in white adipose tissue. Exerc Immunol Rev 2023; 29: 111-120."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/0008-5472.CAN-19-1601","article-title":"Host Wnt5a potentiates microenvironmental regulation of ovarian cancer metastasis","volume":"80","author":"Asem","year":"2020","unstructured":"Asem M, Young AM, Oyama C, Claure De La Zerda A, Liu Y, Yang J, Hilliard TS, Johnson J, Harper EI, Guldner I, Zhang S, Page-Mayberry T, Kaliney WJ and Stack MS. Host Wnt5a potentiates microenvironmental regulation of ovarian cancer metastasis. Cancer Res 2020; 80: 1156-1170.","journal-title":"Cancer Res"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13046-022-02592-y","article-title":"Cancer-educated mammary adipose tissue-derived stromal\/stem cells in obesity and breast cancer: spatial regulation and function","volume":"42","author":"Ritter","year":"2023","unstructured":"Ritter A, Kreis NN, Roth S, Friemel A, Safdar BK, Hoock SC, Wildner JM, Allert R, Louwen F, Solbach C and Yuan J. Cancer-educated mammary adipose tissue-derived stromal\/stem cells in obesity and breast cancer: spatial regulation and function. J Exp Clin Cancer Res 2023; 42: 35.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","unstructured":"Chen Y, McAndrews KM and Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol 2021; 18: 792-804.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41417-021-00318-4","article-title":"Cancer-associated fibroblasts: overview, progress, challenges, and directions","volume":"28","author":"Ping","year":"2021","unstructured":"Ping Q, Yan R, Cheng X, Wang W, Zhong Y, Hou Z, Shi Y, Wang C and Li R. Cancer-associated fibroblasts: overview, progress, challenges, and directions. Cancer Gene Ther 2021; 28: 984-999.","journal-title":"Cancer Gene Ther"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"9915312","DOI":"10.1155\/2021\/9915312","article-title":"Ferroptosis-related gene signature promotes ovarian cancer by influencing immune infiltration and invasion","volume":"2021","author":"You","year":"2021","unstructured":"You Y, Fan Q, Huang J, Wu Y, Lin H and Zhang Q. Ferroptosis-related gene signature promotes ovarian cancer by influencing immune infiltration and invasion. J Oncol 2021; 2021: 9915312.","journal-title":"J Oncol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","article-title":"Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance","volume":"80","author":"Mukherjee","year":"2020","unstructured":"Mukherjee A, Chiang CY, Daifotis HA, Nieman KM, Fahrmann JF, Lastra RR, Romero IL, Fiehn O and Lengyel E. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res 2020; 80: 1748-1761.","journal-title":"Cancer Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3892\/or.2020.7647","article-title":"Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4","volume":"44","author":"Zhou","year":"2020","unstructured":"Zhou S, Wang R and Xiao H. Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4. Oncol Rep 2020; 44: 927-938.","journal-title":"Oncol Rep"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"13316","DOI":"10.1038\/s41598-019-49649-1","article-title":"Adipocytes promote ovarian cancer chemoresistance","volume":"9","author":"Yang","year":"2019","unstructured":"Yang J, Zaman MM, Vlasakov I, Roy R, Huang L, Martin CR, Freedman SD, Serhan CN and Moses MA. Adipocytes promote ovarian cancer chemoresistance. Sci Rep 2019; 9: 13316.","journal-title":"Sci Rep"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3390\/nu11122839","article-title":"Hormonal therapy resistance and breast cancer: involvement of adipocytes and leptin","volume":"11","author":"Delort","year":"2019","unstructured":"Delort L, Bougaret L, Cholet J, Vermerie M, Billard H, Decombat C, Bourgne C, Berger M, Dumontet C and Caldefie-Chezet F. Hormonal therapy resistance and breast cancer: involvement of adipocytes and leptin. Nutrients 2019; 11: 2839.","journal-title":"Nutrients"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Au Yeung","year":"2016","unstructured":"Au Yeung CL, Co NN, Tsuruga T, Yeung TL, Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, Schmandt R, Lu KH and Mok SC. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun 2016; 7: 11150.","journal-title":"Nat Commun"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41417-020-0195-6","article-title":"Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt\/β-catenin signaling pathway","volume":"28","author":"Ruan","year":"2021","unstructured":"Ruan Z, Lu L, Zhang L and Dong M. Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt\/β-catenin signaling pathway. Cancer Gene Ther 2021; 28: 785-798.","journal-title":"Cancer Gene Ther"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3892\/ijmm.2020.4634","article-title":"Exosomal microRNA-146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2-mediated PI3K\/Akt axis","volume":"46","author":"Qiu","year":"2020","unstructured":"Qiu L, Wang J, Chen M, Chen F and Tu W. Exosomal microRNA-146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2-mediated PI3K\/Akt axis. Int J Mol Med 2020; 46: 609-620.","journal-title":"Int J Mol Med"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12967-020-02652-x","article-title":"Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting MYB","volume":"19","author":"Li","year":"2021","unstructured":"Li P, Xin H and Lu L. Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting MYB. J Transl Med 2021; 19: 4.","journal-title":"J Transl Med"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1099459","DOI":"10.3389\/fimmu.2023.1099459","article-title":"Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment","volume":"14","author":"Surendran","year":"2023","unstructured":"Surendran A, Jamalkhah M, Poutou J, Birtch R, Lawson C, Dave J, Crupi MJF, Mayer J, Taylor V, Petryk J, de Souza CT, Moodie N, Billingsley JL, Austin B, Cormack N, Blamey N, Rezaei R, McCloskey CW, Fekete EEF, Birdi HK, Neault S, Jamieson TR, Wylie B, Tucker S, Azad T, Vanderhyden B, Tai LH, Bell JC and Ilkow CS. Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment. Front Immunol 2023; 14: 1099459.","journal-title":"Front Immunol"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Finley LWS. What is cancer metabolism? Cell 2023; 186: 1670-1688.","DOI":"10.1016\/j.cell.2023.01.038"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms231710037","article-title":"Revisited metabolic control and reprogramming cancers by means of the warburg effect in tumor cells","volume":"23","author":"Fukushi","year":"2022","unstructured":"Fukushi A, Kim HD, Chang YC and Kim CH. Revisited metabolic control and reprogramming cancers by means of the warburg effect in tumor cells. Int J Mol Sci 2022; 23: 10037.","journal-title":"Int J Mol Sci"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/biom12040580","article-title":"Effects of glucose metabolism, lipid metabolism, and glutamine metabolism on tumor microenvironment and clinical implications","volume":"12","author":"Zhu","year":"2022","unstructured":"Zhu L, Zhu X and Wu Y. Effects of glucose metabolism, lipid metabolism, and glutamine metabolism on tumor microenvironment and clinical implications. Biomolecules 2022; 12: 580.","journal-title":"Biomolecules"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/CMAR.S421771","article-title":"Role of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4) in tumor cells and the tumor microenvironment","volume":"15","author":"Liu","year":"2023","unstructured":"Liu T, Han S, Yao Y and Zhang G. Role of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4) in tumor cells and the tumor microenvironment. Cancer Manag Res 2023; 15: 957-975.","journal-title":"Cancer Manag Res"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn UE","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F and Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol 2017; 14: 11-31.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"11691","DOI":"10.3390\/ijms241411691","article-title":"The involvement of polyunsaturated fatty acids in apoptosis mechanisms and their implications in cancer","volume":"24","author":"Montecillo-Aguado","year":"2023","unstructured":"Montecillo-Aguado M, Tirado-Rodriguez B and Huerta-Yepez S. The involvement of polyunsaturated fatty acids in apoptosis mechanisms and their implications in cancer. Int J Mol Sci 2023; 24: 11691.","journal-title":"Int J Mol Sci"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment","volume":"38","author":"Motohara","year":"2019","unstructured":"Motohara T, Masuda K, Morotti M, Zheng Y, El-Sahhar S, Chong KY, Wietek N, Alsaadi A, Carrami EM, Hu Z, Artibani M, Gonzalez LS, Katabuchi H, Saya H and Ahmed AA. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene 2019; 38: 2885-2898.","journal-title":"Oncogene"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-019-2221-x","article-title":"SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K\/Akt signaling pathway","volume":"11","author":"Zhao","year":"2020","unstructured":"Zhao J, Zhang X, Gao T, Wang S, Hou Y, Yuan P, Yang Y, Yang T, Xing J, Li J and Liu S. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K\/Akt signaling pathway. Cell Death Dis 2020; 11: 25.","journal-title":"Cell Death Dis"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis","volume":"37","author":"Ladanyi","year":"2018","unstructured":"Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, Yamada SD, Abumrad NA and Lengyel E. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 2018; 37: 2285-2301.","journal-title":"Oncogene"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3390\/cancers13143541","article-title":"Arginine signaling and cancer metabolism","volume":"13","author":"Chen","year":"2021","unstructured":"Chen CL, Hsu SC, Ann DK, Yen Y and Kung HJ. Arginine signaling and cancer metabolism. Cancers (Basel) 2021; 13: 3541.","journal-title":"Cancers (Basel)"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Petrus P, Lecoutre S, Dollet L, Wiel C, Sulen A, Gao H, Tavira B, Laurencikiene J, Rooyackers O, Checa A, Douagi I, Wheelock CE, Arner P, McCarthy M, Bergo MO, Edgar L, Choudhury RP, Aouadi M, Krook A and Rydén M. Glutamine links obesity to inflammation in human white adipose tissue. Cell Metab 2020; 31: 375-390, e311.","DOI":"10.1016\/j.cmet.2019.11.019"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ymben.2021.12.005","article-title":"Coordinated reprogramming of metabolism and cell function in adipocytes from proliferation to differentiation","volume":"69","author":"Oates","year":"2022","unstructured":"Oates EH and Antoniewicz MR. Coordinated reprogramming of metabolism and cell function in adipocytes from proliferation to differentiation. Metab Eng 2022; 69: 221-230.","journal-title":"Metab Eng"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Wen YA, Xing X, Harris JW, Zaytseva YY, Mitov MI, Napier DL, Weiss HL, Mark Evers B and Gao T. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis 2017; 8: e2593.","DOI":"10.1038\/cddis.2017.21"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"599915","DOI":"10.3389\/fonc.2020.599915","article-title":"How autophagy shapes the tumor microenvironment in ovarian cancer","volume":"10","author":"Ferraresi","year":"2020","unstructured":"Ferraresi A, Girone C, Esposito A, Vidoni C, Vallino L, Secomandi E, Dhanasekaran DN and Isidoro C. How autophagy shapes the tumor microenvironment in ovarian cancer. Front Oncol 2020; 10: 599915.","journal-title":"Front Oncol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fcell.2019.00185","article-title":"Emerging roles of lipophagy in health and disease","volume":"7","author":"Kounakis","year":"2019","unstructured":"Kounakis K, Chaniotakis M, Markaki M and Tavernarakis N. Emerging roles of lipophagy in health and disease. Front Cell Dev Biol 2019; 7: 185.","journal-title":"Front Cell Dev Biol"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"de Candia P, Prattichizzo F, Garavelli S, Alviggi C, La Cava A and Matarese G. The pleiotropic roles of leptin in metabolism, immunity, and cancer. J Exp Med 2021; 218: e20191593.","DOI":"10.1084\/jem.20191593"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ and Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol 2016; 34: 4270-4276.","journal-title":"J Clin Oncol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrendo.2017.90","article-title":"Adapting to obesity with adipose tissue inflammation","volume":"13","author":"Reilly","year":"2017","unstructured":"Reilly SM and Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol 2017; 13: 633-643.","journal-title":"Nat Rev Endocrinol"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"D’Souza RF, Masson SWC, Woodhead JST, James SL, MacRae C, Hedges CP and Merry TL. α1-Antitrypsin A treatment attenuates neutrophil elastase accumulation and enhances insulin sensitivity in adipose tissue of mice fed a high-fat diet. Am J Physiol Endocrinol Metab 2021; 321: E560-E570.","DOI":"10.1152\/ajpendo.00181.2021"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Li B, Liu S, Yang Q, Li Z, Li J, Wu J, Sun S, Xu Z, Sun S and Wu Q. Macrophages in tumor-associated adipose microenvironment accelerate tumor progression. Adv Biol (Weinh) 2023; 7: e2200161.","DOI":"10.1002\/adbi.202200161"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13045-018-0625-1","article-title":"Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties","volume":"11","author":"Wang","year":"2018","unstructured":"Wang S, Xu M, Li X, Su X, Xiao X, Keating A and Zhao RC. Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties. J Hematol Oncol 2018; 11: 82.","journal-title":"J Hematol Oncol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1038\/s41467-022-33800-0","article-title":"The hippo pathway links adipocyte plasticity to adipose tissue fibrosis","volume":"13","author":"Shen","year":"2022","unstructured":"Shen H, Huang X, Zhao Y, Wu D, Xue K, Yao J, Wang Y, Tang N and Qiu Y. The hippo pathway links adipocyte plasticity to adipose tissue fibrosis. Nat Commun 2022; 13: 6030.","journal-title":"Nat Commun"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-15-1177","article-title":"Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy","volume":"6","author":"Incio","year":"2016","unstructured":"Incio J, Liu H, Suboj P, Chin SM, Chen IX, Pinter M, Ng MR, Nia HT, Grahovac J, Kao S, Babykutty S, Huang Y, Jung K, Rahbari NN, Han X, Chauhan VP, Martin JD, Kahn J, Huang P, Desphande V, Michaelson J, Michelakos TP, Ferrone CR, Soares R, Boucher Y, Fukumura D and Jain RK. Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy. Cancer Discov 2016; 6: 852-869.","journal-title":"Cancer Discov"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1158\/1078-0432.CCR-13-2270","article-title":"Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer","volume":"20","author":"Pola&#x144","year":"2014","unstructured":"Polański R, Hodgkinson CL, Fusi A, Nonaka D, Priest L, Kelly P, Trapani F, Bishop PW, White A, Critchlow SE, Smith PD, Blackhall F, Dive C and Morrow CJ. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. Clin Cancer Res 2014; 20: 926-937.","journal-title":"Clin Cancer Res"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1158\/1078-0432.CCR-18-3421","article-title":"Breast phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression, which can be inhibited by CCR5 inhibition therapy","volume":"25","author":"Nie","year":"2019","unstructured":"Nie Y, Huang H, Guo M, Chen J, Wu W, Li W, Xu X, Lin X, Fu W, Yao Y, Zheng F, Luo ML, Saw PE, Yao H, Song E and Hu H. Breast phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression, which can be inhibited by CCR5 inhibition therapy. Clin Cancer Res 2019; 25: 3873-3886.","journal-title":"Clin Cancer Res"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"38498","DOI":"10.1038\/srep38498","article-title":"Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells","volume":"6","author":"AMMT","year":"2016","unstructured":"Reza AMMT, Choi YJ, Yasuda H and Kim JH. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells. Sci Rep 2016; 6: 38498.","journal-title":"Sci Rep"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.3390\/ijms21134652","article-title":"Aspirin modifies inflammatory mediators and metabolomic profiles and contributes to the suppression of obesity-associated breast cancer cell growth","volume":"21","author":"Hsieh","year":"2020","unstructured":"Hsieh CC, Chiu HH, Wang CH and Kuo CH. Aspirin modifies inflammatory mediators and metabolomic profiles and contributes to the suppression of obesity-associated breast cancer cell growth. Int J Mol Sci 2020; 21: 4652.","journal-title":"Int J Mol Sci"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/ijmm.2024.5361","article-title":"Adipocyte-rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator-activated receptor gamma\/ABCG2 in epithelial ovarian cancer","volume":"53","author":"Chen","year":"2024","unstructured":"Chen S, Liu Z, Wu H, Wang B, Ouyang Y, Liu J, Zheng X, Zhang H, Li X, Feng X, Li Y, Shen Y, Zhang H, Xiao B, Yu C and Deng W. Adipocyte-rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator-activated receptor gamma\/ABCG2 in epithelial ovarian cancer. Int J Mol Med 2024; 53: 37.","journal-title":"Int J Mol Med"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"118371","DOI":"10.1016\/j.lfs.2020.118371","article-title":"Effects of metformin on adipose-derived stromal cell (ADSC) - Breast cancer cell lines interaction","volume":"261","author":"Teufelsbauer","year":"2020","unstructured":"Teufelsbauer M, Rath B, Plangger A, Staud C, Nanobashvili J, Huk I, Neumayer C, Hamilton G and Radtke C. Effects of metformin on adipose-derived stromal cell (ADSC) - Breast cancer cell lines interaction. Life Sci 2020; 261: 118371.","journal-title":"Life Sci"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/molecules26061506","article-title":"EGCG inhibits adipose-derived mesenchymal stem cells differentiation into adipocytes and prevents a STAT3-mediated paracrine oncogenic control of triple-negative breast cancer cell invasive phenotype","volume":"26","author":"Gonzalez Suarez","year":"2021","unstructured":"Gonzalez Suarez N, Rodriguez Torres S, Ouanouki A, El Cheikh-Hussein L and Annabi B. EGCG inhibits adipose-derived mesenchymal stem cells differentiation into adipocytes and prevents a STAT3-mediated paracrine oncogenic control of triple-negative breast cancer cell invasive phenotype. Molecules 2021; 26: 1506.","journal-title":"Molecules"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1667\/RR14551.1","article-title":"Adipocyte secretome increases radioresistance of malignant melanocytes by improving cell survival and decreasing oxidative status","volume":"187","author":"Coelho","year":"2017","unstructured":"Coelho P, Silva L, Faria I, Vieria M, Monteiro A, Pinto G, Prudêncio C, Fernandes R and Soares R. Adipocyte secretome increases radioresistance of malignant melanocytes by improving cell survival and decreasing oxidative status. Radiat Res 2017; 187: 581-588.","journal-title":"Radiat Res"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41420-023-01306-3","article-title":"Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6","volume":"9","author":"Guo","year":"2023","unstructured":"Guo Z, Zhang H, Fu Y, Kuang J, Zhao B, Zhang L, Lin J, Lin S, Wu D and Xie G. Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell Death Discov 2023; 9: 6.","journal-title":"Cell Death Discov"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev-med-050913-022228","article-title":"Obesity and cancer: local and systemic mechanisms","volume":"66","author":"NM","year":"2015","unstructured":"Iyengar NM, Hudis CA and Dannenberg AJ. Obesity and cancer: local and systemic mechanisms. Annu Rev Med 2015; 66: 297-309.","journal-title":"Annu Rev Med"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","unstructured":"Coussens LM and Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.","journal-title":"Nature"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ijc.31392","article-title":"The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model","volume":"143","author":"Papaevangelou","year":"2018","unstructured":"Papaevangelou E, Almeida GS, Box C, deSouza NM and Chung YL. The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model. Int J Cancer 2018; 143: 992-1002.","journal-title":"Int J Cancer"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"Pagotto A, Pilotto G, Mazzoldi EL, Nicoletto MO, Frezzini S, Pastò A and Amadori A. Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells. Cell Death Dis 2017; 8: e2943.","DOI":"10.1038\/cddis.2017.327"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1158\/1078-0432.CCR-22-1326","article-title":"Bevacizumab may differentially improve prognosis of advanced ovarian cancer patients with low expression of VEGF-A165b, an antiangiogenic VEGF-A splice variant","volume":"28","author":"Wimberger","year":"2022","unstructured":"Wimberger P, Gerber MJ, Pfisterer J, Erdmann K, Füssel S, Link T, du Bois A, Kommoss S, Heitz F, Sehouli J, Kimmig R, de Gregorio N, Schmalfeldt B, Park-Simon TW, Baumann K, Hilpert F, Grube M, Schröder W, Burges A, Belau A, Hanker L and Kuhlmann JD. Bevacizumab may differentially improve prognosis of advanced ovarian cancer patients with low expression of VEGF-A165b, an antiangiogenic VEGF-A splice variant. Clin Cancer Res 2022; 28: 4660-4668.","journal-title":"Clin Cancer Res"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"116296","DOI":"10.1016\/j.biopha.2024.116296","article-title":"In ovarian cancer maraviroc potentiates the antitumoral activity and further inhibits the formation of a tumor-promoting microenvironment by trabectedin","volume":"172","author":"Casagrande","year":"2024","unstructured":"Casagrande N, Borghese C, Corona G and Aldinucci D. In ovarian cancer maraviroc potentiates the antitumoral activity and further inhibits the formation of a tumor-promoting microenvironment by trabectedin. Biomed Pharmacother 2024; 172: 116296.","journal-title":"Biomed Pharmacother"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1080\/14786419.2022.2144298","article-title":"TQ-Ox, a novel synthetic derivative of thymoquinone on ovarian cancer cells in vitro","volume":"37","author":"Kale","year":"2023","unstructured":"Kale E, Kale A, Bozali K, Gulgec AS, Ozdemir M, Yalcin B and Guler EM. TQ-Ox, a novel synthetic derivative of thymoquinone on ovarian cancer cells in vitro. Nat Prod Res 2023; 37: 3015-3024.","journal-title":"Nat Prod Res"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Guo J, Zhu Y, Yu L, Li Y, Guo J, Cai J, Liu L and Wang Z. Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer. PeerJ 2021; 9: e11591.","DOI":"10.7717\/peerj.11591"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13402-015-0235-7","article-title":"Metformin and epithelial ovarian cancer therapeutics","volume":"38","author":"Patel","year":"2015","unstructured":"Patel S, Kumar L and Singh N. Metformin and epithelial ovarian cancer therapeutics. Cell Oncol (Dordr) 2015; 38: 365-375.","journal-title":"Cell Oncol (Dordr)"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/biomedicines11041000","article-title":"Epigallocatechin-3-gallate prevents the acquisition of a cancer stem cell phenotype in ovarian cancer tumorspheres through the inhibition of Src\/JAK\/STAT3 signaling","volume":"11","author":"Rodriguez Torres","year":"2023","unstructured":"Rodriguez Torres S, Gresseau L, Benhamida M, Fernandez-Marrero Y and Annabi B. Epigallocatechin-3-gallate prevents the acquisition of a cancer stem cell phenotype in ovarian cancer tumorspheres through the inhibition of Src\/JAK\/STAT3 signaling. Biomedicines 2023; 11: 1000.","journal-title":"Biomedicines"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/7\/ajcr0156919.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:54:24Z","timestamp":1766022864000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/7\/ajcr0156919.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":129,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/xzri9189","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}